The Use of an IL-1 Receptor Antagonist Peptide to Control Inflammation in the Treatment of Corneal Limbal Epithelial Stem Cell Deficiency

Figure 6

Peptide suppression of cytokine production by IL-1β stimulated LESC. (a) IL-8, (b) IL-6, and (c) IL-1β secretion by LESC when stimulated with IL-1β (10⁻⁹ M) were significantly reduced following the addition of peptide (1000 μg/mL) compared to the no peptide controls (, mean ± sd).

(a)

(b)

(c)